Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Argenta Discovery
Argenta Discovery
Activities:
Research & Development
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Research & Development
Charles River Laboratories to buy research services division of Galapagos for up to €134m
Adds in vitro drug discovery capabilities to service offering
Finance
Boehringer Ingelheim reports double-digit growth in sales for 2012
Plans launches in the oncology sector during 2013
Research & Development
Galapagos acquires Cangenix, a structure-based drug discovery company
Also sets up third drug discovery division called Fidelta
Research & Development
Galapagos acquires Argenta Discovery's service operations
Belgian biotechnology company Galapagos has bought Argenta Discovery 2009, a UK-based privately held contract research drug discovery company with 140 staff, for Euro 16.5m.
Subscribe now